chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: Random sharp heart pain and heart discomfort since getting the vaccine; This is a spontaneous report from a contactable consumer (patient). A 26-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: ER8731) via an unspecified route of administration on 14Apr2021 at 11:00 (at the age of 26-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history was reported as none. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had no known allergies. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks of the COVID-19 vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot Number: ER8733) via an unspecified route of administration on 24Mar2021 at 11:00 (at the age of 26-years-old) as a single dose in the left arm for COVID-19 immunization. On 14Apr2021 at 17:00, the patient experienced random sharp heart pain and heart discomfort since getting the vaccine. Treatment was not received for the event. The clinical outcome of the event random sharp heart pain and heart discomfort since getting the vaccine was not recovered/not resolved. Since the vaccination, the patient had not been tested for COVID-19.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chromaturia, Renal pain, Urine odour abnormal
Clinical narrative: started having pain on left lower side/ Kidney causing pain; Urine was very dark Orange; Urine with a horrible odor; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 25Mar2021 at 17:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes, high blood pressure and allergy to penicillin. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously took erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medications included insulin human (NOVOLIN R), liraglutide (VICTOZA), metformin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN) and aluminium hydroxide, magnesium hydroxide (MAGNESIUM); all were taken for an unknown indication and from unknown start date. On 25Mar2021 at 19:30, in the evening, the patient started having pain on left lower side, then noticed that the urine was very dark orange with a horrible odor, the patient realized that it was kidney causing pain. Still at the time of this report, the patient had off and on pain in kidney and urine had odor off and on and at times the color was darker. The patient had been terrified to report and also afraid to get the second dose as she did not want to hurt the kidney. The patient almost went to urgent care but did not because she was afraid that it was something serious. The patient was in planning to call the doctor to find out whats going on. The events did not result in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain on left lower side, urine was very dark orange and with a horrible odor was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blindness, Vision blurred
Clinical narrative: Could not see; Blurred vision in the left eye; This is a spontaneous report from a contactable consumer (patient). A 53-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 16:15 (Batch/Lot Number: EWU161) as DOSE 2, SINGLE for COVID-19 immunization. Medical history was reported as none. The patient did not have any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ibuprofen (ADVIL) taken for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccinations within four weeks prior to COVID vaccine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 in the left arm on 25Mar2021 at 16:00 (Batch/Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunization. On 16Apr2021 at 04:30, the patient experienced blurred vision in the left eye; woke up 13 hours after the shot and had foggy vision but not bad; got worse throughout the day; by 24 hours after the shot, complete white out in left eye; could not see. The patient did not receive any treatment for the events. The clinical outcome of the blindness and vision blurred was recovered on 17Apr2021 (by 27 hours started to see improvement; woke up 37 hours after shot with vision back). It was reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 46-year-old male patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8735), at the age of 46, via an unspecified route of administration, right arm, on Apr 14, 2021, at 10:30, single dose, for COVID-19 immunisation. Medical history included COVID-19. Patient has no known allergies. Prior to the vaccination, patient diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Patient did not receive any other medications within two weeks of vaccination. On Apr 16, 2021, at 06:00, patient experienced vertigo (dizziness). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of vertigo (dizziness): not recovered (at the time of this report). No follow-up attempts needed. No further information expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Pyrexia, Swelling
Clinical narrative: Chills; fever; underneath arm swollen; underneath my arm is swollen going into the third day after my shot which is painful; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the left arm on 14Apr2021 at 15:00 (at the age of 50-year-old) as 0.3ml single dose for COVID-19 immunisation. Medical history was reported as no. The patient had no known allergies to food, medications or other products. The patient received medications (unspecified) within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 15:30 the patient experienced chills, fever for two days, underneath arm swollen which was going into the third day after shot and was painful. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of fever was recovered on 17Apr2021 after a duration of 2 days; while that of chills, underneath arm swollen which was going into the third day after shot and was painful was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hyperhidrosis, Muscular weakness, Vaccination site pain
Clinical narrative: Minor left arm weakness; Stinging at site of injection; Sweaty palms; This is a spontaneous report from a non-contactable consumer, the patient. A patient of unknown age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced minor left arm weakness, stinging at site of injection, sweaty palms. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the events minor left arm weakness, stinging at site of injection and sweaty palms was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Periarthritis, Vaccination site pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 68, via an unspecified route of administration, left arm, on Mar 11, 2021, at 09:00, single dose, for COVID-19 immunisation. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient previously took Penicillin G (benzylpenicillin), for unspecified indication on unknown date; and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in 2021, at 06:00, patient experienced a frozen shoulder and was in physical therapy. The injection site was still sore at the time of report. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures taken as a result of a frozen shoulder included physical therapy for four weeks; and has at least four more to go (twice a week). Since the vaccination, patient has not  tested for COVID-19. The outcome of frozen shoulder and sore injection site sore: not recovered (at the time of this report). No follow-up attempts needed. Information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Breast swelling, Dizziness, Fatigue, Migraine, Pharyngeal swelling
Clinical narrative: swelling at injection site right side; itching at injection site right side; swelling of face right side; swelling of throat right side; swelling of underarm right side; swelling of breast right side; migraine type headaches; dizziness; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0151) via an unspecified route of administration in the right arm on 13Apr2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, hormone replacement therapy and COVID-19. The patient was allergic to sulfur. Concomitant medications included amlodipine besilate (AMLODIPINE BESYLATE) and estradiol (MANUFACTURER UNKNOWN); taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced adverse events all on right side which included swelling and itching at injection site, swelling of face, swelling of throat, swelling of underarm, swelling of breast. The patient had side effects which include migraine type headaches, dizziness and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events swelling and itching at injection site, swelling of face, swelling of throat, swelling of underarm, swelling of breast and included treatment with prednisone (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling at injection site right side, itching at injection site right side, swelling of face right side, swelling of throat right side, swelling of underarm right side, swelling of breast right side, migraine type headaches, dizziness and fatigue were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Swelling face, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: swelling at injection site right side; itching at injection site right side; swelling of face right side; swelling of throat right side; swelling of underarm right side; swelling of breast right side; migraine type headaches; dizziness; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0151) via an unspecified route of administration in the right arm on 13Apr2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, hormone replacement therapy and COVID-19. The patient was allergic to sulfur. Concomitant medications included amlodipine besilate (AMLODIPINE BESYLATE) and estradiol (MANUFACTURER UNKNOWN); taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via an unspecified route of administration in the left arm on 24Mar2021 at 16:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced adverse events all on right side which included swelling and itching at injection site, swelling of face, swelling of throat, swelling of underarm, swelling of breast. The patient had side effects which include migraine type headaches, dizziness and fatigue. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events swelling and itching at injection site, swelling of face, swelling of throat, swelling of underarm, swelling of breast and included treatment with prednisone (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling at injection site right side, itching at injection site right side, swelling of face right side, swelling of throat right side, swelling of underarm right side, swelling of breast right side, migraine type headaches, dizziness and fatigue were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Illness, Pain, Vomiting
Clinical narrative: Became violently ill a few hours later; Vomiting; Chills; Body pain; Redness all over; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ew0160) via an unspecified route of administration in the left arm on 15Apr2021 at 15:15 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. Medical history included migraine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included nortriptyline (MANUFACTURER UNKNOWN) on an unknown date for unknown indication and unknown if ongoing. The patient previously took paracetamol (TYLENOL) for unknown indication on unknown date and experienced drug allergy. On 15Apr2021 at 20:00, few hours later, the patient experienced violently ill, vomiting, chills, body pain and redness all over. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events violently ill a few hours later, vomiting, chills, body pain and redness all over were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Pruritus, Rash
Clinical narrative: I had shortness of breath and rash on both arms and left leg as well as both sides near my stomach with intense itching in all the rash areas; I had shortness of breath and rash on both arms and left leg as well as both sides near my stomach with intense itching in all the rash areas; I had shortness of breath and rash on both arms and left leg as well as both sides near my stomach with intense itching in all the rash areas; This is a spontaneous report from a contactable consumer (patient himself). A 53-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number and expiration date was not reported) via an unspecified route of administration, administered in Arm Right on 06Apr2021 18:30 (at age of 53-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. Medical history included hypertension and blood cholesterol increased from an unknown date and unknown if ongoing. Concomitant medications included amlodipine (AMLODIPINE) and losartan (LOSARTAN) taken for an unspecified indication. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. On 08Apr2021 08:00 the patient experienced I had shortness of breath and rash on both arms and left leg as well as both sides near my stomach with intense itching in all the rash areas. The adverse event resulted in physician office visit. Patient had received treatment for AEs; prescription for the itching (treatment/drug not specified). Since the vaccination, patient has not been tested for COVID-19. The outcome of events was recovering.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blepharospasm, Muscular weakness, Pain in extremity
Clinical narrative: Area around right eye twitching; right arm weakness.; right arm pain.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 05Apr2021 at 12:00(at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic migraine and exercise induced asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ibuprofen (ADVIL), taken for an unknown indication from an unknown start date and unknown if ongoing. Patient had no known allergies to food, medication or other products. On 07Apr2021 at 00:00, the patient experienced twitching in the area around right eye and right arm weakness/pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events twitching in the area around right eye and right arm weakness/pain was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site pain
Clinical narrative: injection site pretty sore; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6207) via an unspecified route of administration on 16Apr2021 at 13:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, COVID-19. Patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), loratadine; pseudoephedrine sulfate (CLARITIN-D) and amlodipine besilate (NORVASC) all from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en6199) via an unspecified route of administration on 02Mar2021 at 10:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 06:00, the patient experienced injection site was pretty sore that morning. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event injection site was pretty sore that morning was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Eye inflammation, SARS-CoV-2 test
Clinical narrative: Conjunctivitis like eye inflammation; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8724) via an unspecified route of administration in the left arm on 10Apr2021 at 12:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications were not reported. On 14Apr2021, the patient experienced conjunctivitis like eye inflammation. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. On 15Apr2021, the patient underwent SARS COV-2 Test (Nasal swab) and the result was negative. The clinical outcome of the event conjunctivitis like eye inflammation was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Swelling, Swelling of eyelid
Clinical narrative: Swollen on right side of fore head.; 4 days later, swollen left eye lid area; Sore left arm shoulder area; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO151) via an unspecified route of administration in the left arm on 06Apr2021 at 13:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, sulfonamide allergy, latex allergy and iodine allergy (iodine in seafood). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 19:00 the patient experienced sore left arm shoulder area. On 10Apr2021, 4 days after the vaccination the patient experienced swollen left eye lid area. On 17Apr2021,11 days after the vaccination the patient experienced swollen on right side of fore head. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore left arm shoulder area 4 days later, swollen left eye lid area, 11 days later swollen on right side of fore head were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Pruritus, Rash, Skin burning sensation
Clinical narrative: Constant Itching; Burning sensation under skin; Strange bumps begun to appear (especially on face); Arms have a slight rash; Fingers, wrist, and ankles intermittently hurt (sometimes); Fingers, wrist, and ankles intermittently hurt (sometimes); This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation, epilepsy, and COVID-19. The patient had an allergy to fish and bananas. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included oxcarbazepine (TRILEPTAL), sotalol (MANUFACTURER UNKNOWN), topiramate (MANUFACTURER UNKNOWN), "hydrochlo" (MANUFACTURER UNKNOWN), and apixaban (ELIQUIS); all for an unknown indication from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 13:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient previously received phenytoin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 07Apr2021, the patient experienced constant itching and a burning sensation under the skin. On the same day, strange bumps began to appear (especially on the face), arms had a slight rash, and fingers, wrist, and ankles were intermittently (sometimes) hurt. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events constant itching, burning sensation under skin, strange bumps begun to appear (especially on face), arms have a slight rash, and fingers, wrist, and ankles intermittently hurt (sometimes) were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Skin disorder
Clinical narrative: Constant Itching; Burning sensation under skin; Strange bumps begun to appear (especially on face); Arms have a slight rash; Fingers, wrist, and ankles intermittently hurt (sometimes); Fingers, wrist, and ankles intermittently hurt (sometimes); This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation, epilepsy, and COVID-19. The patient had an allergy to fish and bananas. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included oxcarbazepine (TRILEPTAL), sotalol (MANUFACTURER UNKNOWN), topiramate (MANUFACTURER UNKNOWN), "hydrochlo" (MANUFACTURER UNKNOWN), and apixaban (ELIQUIS); all for an unknown indication from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 13:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient previously received phenytoin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 07Apr2021, the patient experienced constant itching and a burning sensation under the skin. On the same day, strange bumps began to appear (especially on the face), arms had a slight rash, and fingers, wrist, and ankles were intermittently (sometimes) hurt. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events constant itching, burning sensation under skin, strange bumps begun to appear (especially on face), arms have a slight rash, and fingers, wrist, and ankles intermittently hurt (sometimes) were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Heart rate, Heart rate increased, Palpitations
Clinical narrative: Resting heart rate had increased from 68 pre vaccine to between 98 and 105 after vaccine; It was very hard to do even light physical activities without getting dizzy; Feeling heart race; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 13Apr2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included type-2 diabetes mellitus and hypogonadism. The patient had no allergies to food, medications, or other products. Concomitant medications included testosterone (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), empagliflozin (JARDIANCE) and fenofibrate (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient's resting heart rate had increased from 68 pre-vaccine to between 98 and 105 after the vaccine. It was very hard for him to do even light physical activities without getting dizzy and the patient felt his heart racing. The patient had been out sick from work and went to the emergency room due to this very scary reaction. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events resting heart rate increased, hard to do light physical activities without getting dizzy and heart racing were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Lacrimation increased, Rhinorrhoea, Sneezing
Clinical narrative: Within first hour of inoculation sneezing, runny nose and watery eyes for the first 24 hours; Within first hour of inoculation sneezing, runny nose and watery eyes for the first 24 hours; Within first hour of inoculation sneezing, runny nose and watery eyes for the first 24 hours; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8733) via an unspecified route of administration on an unknown date (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history and medication received within two weeks of vaccination was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was not reported if the patient received any other vaccines within four weeks prior to the vaccination. On an unknown date, within first hour of inoculation the patient experienced sneezing, runny nose and watery eyes for the first 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events within first hour of inoculation sneezing, runny nose and watery eyes for the first 24 hours was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 57-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0158), at the age of 57, via an unspecified route of administration, left arm, on Apr 14, 2021, at 13:15, single dose, for COVID-19 immunisation. Medical history included high blood pressure from an unknown date. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medication included amlodipine besylate for an unknown indication; from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6207) at the age of 57, via an unspecified route of administration, left arm, on Mar 24, 2021, at 13:15, single dose, for COVID-19 immunisation. The patient previously received doxycycline, Ceftin (cefuroxime axetil), hydrochlorothiazide, Augmentin (amoxicillin/clavulanic acid) and Lotrel (amlodipine besylate/benazepril hydrochloride); and experienced drug allergy. On Apr 15, 2021, at 02:00, patient experienced swollen lymph node at collar bone area on the left-side (same side as injection). It was very large and slightly sore. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of swollen lymph node at collar bone area on the left-side and very large lymph node and slightly sore: unknown (at the time of this report). No follow-up attempts needed. No further information expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Migraine, Nausea, Pain, Pyrexia
Clinical narrative: Fever; Chills; body aches; Migraine; Nausea; Vomiting; Blurry vision; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 at 10:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Other medical history included autoimmune disorder nos.  Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and propranolol (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 at 10:45, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 00:00, the patient experienced fever, chills, body aches, migraine three days, nausea, vomiting and blurry vision. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of fever, chills, body aches, nausea, vomiting and blurry vision was recovering while the clinical outcome of the event of migraine was recovered on 18Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Vomiting
Clinical narrative: Fever; Chills; body aches; Migraine; Nausea; Vomiting; Blurry vision; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 at 10:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Other medical history included autoimmune disorder nos.  Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and propranolol (MANUFACTURER UNKNOWN); all from unknown dates for unknown indications and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in 2021 at 10:45, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021 at 00:00, the patient experienced fever, chills, body aches, migraine three days, nausea, vomiting and blurry vision. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of fever, chills, body aches, nausea, vomiting and blurry vision was recovering while the clinical outcome of the event of migraine was recovered on 18Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: About 5 hours after the shot, started trembling uncontrollably.; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0170) via an unspecified route of administration in the right arm on 16Apr2021 at 16:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included Ehlers Danlos syndrome, hypothyroidism and mast cell activation syndrome. The patient was allergic to penicillin and latex. Concomitant medications included acetazolamide (DIAMOX), baclofen (MANUFACTURER UNKNOWN), famotidine (PEPCID), montelukast sodium (SINGULAIR) and levothyroxine sodium (TIROSINT); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 26Mar2021 at 16:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 21:15, about 5 hours after the shot, the patient started trembling uncontrollably for about half an hour, and then it resolved. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event about 5 hours after the shot, started trembling uncontrollably was resolved on 16Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Muscle tightness, Muscle twitching, Pain in extremity
Clinical narrative: First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; First dose- Sore arm. Mild headache and tightness in neck/jaw for 2 weeks. Numbness and twitching in both hands.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 05Apr2021 at 17:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications taken within two weeks of vaccination were reported as not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 06:00, with first dose, the patient experienced sore arm. On 06Apr2021 at 06:00, the patient also had mild headache and tightness in neck/jaw for two weeks. The patient experienced numbness and twitching in both hands on 06Apr2021 at 06:00. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore arm, mild headache and tightness in neck/jaw for two weeks, numbness and twitching in both hands were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Feeding disorder, Headache, Malaise
Clinical narrative: Could not eat; Feeling really sick; Dizzy; Bad Rash; Headache; Nauseous; Throwing up; Redness; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm right on 16Apr2021 at 11:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, arthritis, diverticulosis, gastric issues, anxiety, depression, post-traumatic stress disorder (PTSD) and iodine allergy. The patient previously took Bactrim, carbamazepine, propranolol, Tessalon Perles and ketorolac and experienced allergy to the medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received vaccines within four weeks prior to the vaccination. Concomitant medications included amitriptyline hydrochloride (ELAVIL), salbutamol sulfate (PROAIR HFA) budesonide; formoterol fumarate (SYMBICORT) all for an unknown indication from unknown dates and medroxyprogesterone acetate (DEPO-PROVERA) on14Apr2021 for an unknown indication. On 16Apr2021 at 11:30, the patient experienced bad rash, headache, nauseous, throwing up and dizzy. The patient woke up the next day on 17Apr2021 and still had rash and redness and also experienced feeling really sick and could not eat. Therapeutic measures were taken as a result of events and included treatment with Benadryl and Zofran and they called emergency medical technician (emt). The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events, bad rash, headache, nauseous, throwing up, dizzy, redness, feeling really sick and could not eat was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash, Vomiting
Clinical narrative: Could not eat; Feeling really sick; Dizzy; Bad Rash; Headache; Nauseous; Throwing up; Redness; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the arm right on 16Apr2021 at 11:00 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, arthritis, diverticulosis, gastric issues, anxiety, depression, post-traumatic stress disorder (PTSD) and iodine allergy. The patient previously took Bactrim, carbamazepine, propranolol, Tessalon Perles and ketorolac and experienced allergy to the medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received vaccines within four weeks prior to the vaccination. Concomitant medications included amitriptyline hydrochloride (ELAVIL), salbutamol sulfate (PROAIR HFA) budesonide; formoterol fumarate (SYMBICORT) all for an unknown indication from unknown dates and medroxyprogesterone acetate (DEPO-PROVERA) on14Apr2021 for an unknown indication. On 16Apr2021 at 11:30, the patient experienced bad rash, headache, nauseous, throwing up and dizzy. The patient woke up the next day on 17Apr2021 and still had rash and redness and also experienced feeling really sick and could not eat. Therapeutic measures were taken as a result of events and included treatment with Benadryl and Zofran and they called emergency medical technician (emt). The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events, bad rash, headache, nauseous, throwing up, dizzy, redness, feeling really sick and could not eat was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.